AzTrials
AzTrials

AnxietyNCT07227181

Animal Assisted Therapy

A study testing Therapy Dog and Standard mobilization in people with Anxiety and Trauma, run by Andrew Bernard at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study looks at whether walking with a therapy dog helps adult and pediatric trauma patients move more during their hospital stay. Early movement after an injury or surgery can prevent problems such as blood clots, pressure sores, and muscle loss, but pain and anxiety often make it hard for patients to get out of… Read more about this study

Who is it for?
Ages 4 to 99 years
Conditions the study is for
Anxiety, Trauma, Hospitalized Adult Patients
What is being tested?
Therapy Dog and Standard mobilization
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteUnited States
Study dates
23 Jul 2025to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 99 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Adults (18 years of age and older)
  • trauma patients
  • emergency general surgery patients
  • pediatric patients (4 - 17 years old)

Who cannot join

  • weight bearing limitation
  • spine instability
  • oxygen requirement >2LPM, GCS <15,
  • high fall risk (as evidenced by door label)
  • fear of dogs
  • allergies to dogs
  • prisoners

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Andrew Bernard, MD contact

8593236346

andrew.bernard@uky.edu

United States1 site, 1 recruiting
  • University of Kentucky Albert B. Chandler Hospital

    Lexington, Kentucky, 40515-9578

    Jessica C Borzansky, 8593586642, jcbo251@uky.edu

    Andrew C Bernard, MD, andrew.bernard@uky.edu

    Recruiting

Other trials in United States

About this study

Official title: Effects of Animal-Assisted Therapy on Trauma Patient's Willingness to Participate in Ambulation

This study looks at whether walking with a therapy dog helps adult and pediatric trauma patients move more during their hospital stay. Early movement after an injury or surgery can prevent problems such as blood clots, pressure sores, and muscle loss, but pain and anxiety often make it hard for patients to get out of bed.

Each patient in this study takes part in two walking sessions-one with a certified therapy dog and one without a dog. The order is randomized, so some patients walk with the dog first and others walk without the dog first. Before and after each walk, patients fill out short surveys about their pain, anxiety, and motivation to move. The research team measures how far and how long each patient walks in both sessions.

The goal of this project is to see if therapy dog visits can safely and effectively improve mobility, reduce pain and anxiety, and make walking more enjoyable for trauma patients. Findings from this study may help hospitals design better rehabilitation programs that use animal-assisted therapy to support physical and emotional recovery.

Read the detailed description

Early mobilization after traumatic injury is a key component of recovery and is associated with reduced complications, shorter hospital stays, and improved functional outcomes. However, trauma patients frequently experience significant barriers to early ambulation, including pain, anxiety, fatigue, and psychological distress following injury and surgery. Animal-assisted interventions (AAI) have demonstrated benefits in reducing pain and anxiety, enhancing mood, and improving patient motivation in various hospital settings. Despite these findings, limited research has examined the role of therapy dogs in promoting early mobility specifically among adult trauma inpatients.

This randomized crossover trial investigates the effect of animal-assisted ambulation on walking duration, distance, and patient-reported outcomes among adult trauma patients admitted to an academic Level I trauma center. Each enrolled participant completes two ambulation sessions within their hospital stay: one with the presence of a certified therapy dog and handler, and one without a dog (standard physical therapy or nursing-led walk). The order of sessions is randomized to control for order effects, and all participants serve as their own control.

During each session, objective ambulation data-including walking duration (minutes), and assistance level-are recorded by the research team or physical therapy staff. Pre- and post-session self-report measures assess pain (DVPRS), Wong-Baker Faces scale (peds), anxiety (Modified GAD-7), and motivation to mobilize (Likert scale).

The study aims to evaluate whether therapy dog-assisted ambulation results in greater walking duration and distance, as well as reduced perceived pain and anxiety, compared to standard ambulation without a therapy dog. Secondary analyses will explore potential moderating effects of time of day, patient demographics, and mechanism of injury on intervention effectiveness.

All therapy dogs and handlers are registered through a national certification organization and follow strict infection control and safety protocols consistent with institutional policy. Data will be analyzed using mixed-effects models to account for within-subject correlations and to assess crossover effects.

This study is designed to inform evidence-based integration of animal-assisted therapy into trauma rehabilitation protocols, supporting both the physical and psychosocial dimensions of recovery in hospitalized trauma patients

Additional cohort of the study (pediatric trauma) population has been added.

Being tested
Therapy Dog, Standard mobilization
Keywords
Animal-Assisted Therapy, Therapy Dog, Trauma Patients, Early Mobilization, Anxiety Reduction, Pain Reduction, Human-Animal Interaction
Medical subject headings
Anxiety Disorders, Wounds and Injuries, Human-Animal Interaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Therapy DogOther

    Patients assigned to AAI in the morning received standard mobilization in the afternoon, and vice versa. In the AAI intervention, patients interacted with the therapy dog and handler

  • Standard mobilizationOther

    Patients assigned to AAI in the morning received standard mobilization in the afternoon, and vice versa. Standard mobilization no therapy dog is present

Study groups in NCT07227181
Study groupRoleWhat they receive
Animal-assisted interventionExperimentalTrauma patients participating in Animal Assisted Intervention
Receives: Other: Therapy Dog; Other: Standard mobilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Defense & Veterans Pain Rating Scale

    Before and after each intervention, patients completed surveys assessing pain using the (Defense and Veterans Pain Rating Scale, DVPRS). Scores on the scale ranged from 0: no pain to 10: worst pain of patient's life.

    Measured: baseline and post intervention (1 day)

  2. Change in General Anxiety Disorder-7 (GAD-7) Scale

    Before and after each intervention, patients completed surveys assessing anxiety using modified General Anxiety Disorder-7 (GAD-7). Scaled from not at all to a lot, resulting in a total score that can range from not at all, a litte, some, a lot, with higher values reflecting more severe anxiety symptoms.

    Measured: Baseline and post intervention (1 day)

  3. General status

    Before and after each intervention, patients completed surveys assessing general status. Used likert scale ranging from very poor to excellent.

    Measured: baseline and post intervention (1 day)

  4. Willingness to mobilize

    Before and after each intervention, patients completed surveys assessing willingness to mobilize. Used likert scale ranging from no motivation at all to very much.

    Measured: baseline and post intervention (1day)

  5. Mobilization difficulty

    Before and after each intervention, patients completed surveys assessing mobilization difficulty. Used likert scale ranging from very easy to very hard.

    Measured: Baseline and post intervention (1 day)

  6. Overall mobility satisfaction

    Before and after each intervention, patients completed surveys assessing overall mobility satisfaction. Used likert scale ranging from not satisfied to very satisfied.

    Measured: Baseline and post intervention (1 day)

  7. Change in Wong-Baker Faces Scale

    Before and after each intervention, pediatric patients will use Wong-Baker FACES Pain Rating Scale to assess pain. Scores on the scale ranged from 0: "no hurt" to 10: "hurts worst." Participants ages 4-7 will use a modified FACES and 8-17 will use a regular FACES.

    Measured: Baseline and post intervention (1day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Nov 2025
  2. Study start23 Jul 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07227181
Sponsor's protocol ID
104486
Status last verified
Jul 2026
First submitted
9 Nov 2025
Last updated
24 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Therapy Dog and Standard mobilization in people with Anxiety and Trauma, run by Andrew Bernard at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Andrew Bernard, MD (8593236346, andrew.bernard@uky.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Defense & Veterans Pain Rating Scale (time frame: baseline and post intervention (1 day)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in